Exploring New FDA Initiatives
Stacy Cline Amin
Former Chief Counsel, U.S. FDA
Kurt R. Karst
Hyman, Phelps & McNamara, P.C. (Washington, D.C.)
This panel will discuss how the Agency—now under the leadership of Dr. Califf will move forward with new initiatives including an evolving response to COVID-19 and examine key priorities.